NormOxys Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

NormOxys General Information

Description

Developer of small molecule drugs designed to help in the treatment of cancer. The company's drugs offer a novel allosteric modulator of the affinity of oxygen to hemoglobin which enhances the body's ability to deliver oxygen to diseased tissues, enabling patients to get non-toxic drugs.

Contact Information

Formerly Known As
Oxyplus, Oxyplus Inc
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 300 Market Street
  • Boston, MA 02135
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 300 Market Street
  • Boston, MA 02135
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NormOxys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Sep-2018 Completed Out of Business
3. Later Stage VC 16-Nov-2011 Completed Clinical Trials - Phase 1
2. Later Stage VC (Series B) 25-Mar-2010 $18.6M $26.6M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 18-Nov-2008 $7.98M $7.98M Completed Startup
To view NormOxys’s complete valuation and funding history, request access »

NormOxys Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series B
Series A 1,958,977 $0.000100 5% $4.44 $4.44 1x $4.44 25.19%
To view NormOxys’s complete cap table history, request access »

NormOxys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small molecule drugs designed to help in the treatment of cancer. The company's drugs offer a novel alloste
Drug Discovery
Boston, MA
11 As of 2016

Berkeley, CA
 

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NormOxys Competitors (34)

One of NormOxys’s 34 competitors is Actym Therapeutics, a Venture Capital-Backed company based in Berkeley, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Actym Therapeutics Venture Capital-Backed Berkeley, CA
Priothera Venture Capital-Backed Dublin, Ireland
Kite Pharma Formerly VC-backed Santa Monica, CA
Auron Therapeutics Venture Capital-Backed Newton, MA
Rein Therapeutics Formerly VC-backed Austin, TX
You’re viewing 5 of 34 competitors. Get the full list »

NormOxys Patents

NormOxys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3787634-A1 Inositol-based immunotherapies Inactive 03-May-2018
EP-3787634-A4 Inositol-based immunotherapies Inactive 03-May-2018
US-20210361680-A1 Inositol-based immunotherapies Inactive 03-May-2018
WO-2019213462-A1 Inositol-based immunotherapies Inactive 03-May-2018
EP-2968617-A1 Myo-inositol trispyrophosphate as an anti-obesity agent Inactive 15-Mar-2013 A61K31/6615
To view NormOxys’s complete patent history, request access »

NormOxys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NormOxys FAQs

  • When was NormOxys founded?

    NormOxys was founded in 2004.

  • Where is NormOxys headquartered?

    NormOxys is headquartered in Boston, MA.

  • What is the size of NormOxys?

    NormOxys has 11 total employees.

  • What industry is NormOxys in?

    NormOxys’s primary industry is Drug Discovery.

  • Is NormOxys a private or public company?

    NormOxys is a Private company.

  • What is NormOxys’s current revenue?

    The current revenue for NormOxys is .

  • How much funding has NormOxys raised over time?

    NormOxys has raised $28.7M.

  • Who are NormOxys’s competitors?

    Actym Therapeutics, Priothera, Kite Pharma, Auron Therapeutics, and Rein Therapeutics are some of the 34 competitors of NormOxys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process